PMID- 17403315 OWN - NLM STAT- MEDLINE DCOM- 20081021 LR - 20211203 IS - 0376-2491 (Print) IS - 0376-2491 (Linking) VI - 87 IP - 1 DP - 2007 Jan 2 TI - [Effect of RNA interference targeting mammalian target of rapamycin on the proliferation of vascular smooth muscle cell and the intimal hyperplasia]. PG - 58-62 AB - OBJECTIVE: To construct RNA interference (RNAi) vector of mammalian target of rapamycin (mTOR) and study the effect on the proliferation of vascular smooth muscle cell (VSMC) and the intimal hyperplasia (IH). METHODS: The sequence of short hairpin RNA (shRNA) targeting mTOR was designed and synthesized by chemical method and inserted into a retroviral vector pLXIN, then the vector was packaged in PT67 cells. The efficiency of inhibition was verified by Northern blot and Western blot after transfection to VSMC. The changes of p70s 6k and 4E-BP1 were also determined. The proliferation activity of VSMC was determined by flowcytometry and MTT. Autogenous vein graft model were established in 54 rats. Three groups were divided, including gene therapy group, control group and vein graft group. The grafted veins were harvested 7 days, 14 days and 28 days after transplanting respectively. The expression of mTOR was determined by immunohistochemistry stain and Western blot. IH was also observed. The apoptotic VSMC was determined by TUNEL. RESULTS: The shRNA fragments was inserted into pLXIN vector. The shRNA vector was successfully constructed. Additionally, the vector targeting mTOR gene could efficiently decrease the mRNA and protein expression of mTOR and p70s 6k in VSMC, while the expression of 4E-BP1 increased significantly. The cell cycle of VSMC was stunned in phase G(0)/G(1). The protein expression of mTOR in vein graft was inhibited by transfection of pLXIN-shRNA targeting mTOR (P < 0.01) and the IH was also inhibited (P < 0.01), but the apoptosis of VSMC increased significantly (P < 0.01). CONCLUSION: The mTOR RNAi retroviral vector has been constructed successfully, which can significantly inhibit the proliferation of VSMC and the IH, and promote apoptosis after vein grafting. FAU - Hu, Xin-Hua AU - Hu XH AD - Department of Vascular Surgery, First Affiliated Hospital, China Medical University, Shenyang, China. huxinhuacmu@hotmail.com FAU - Zhang, Qiang AU - Zhang Q FAU - Yang, Jun AU - Yang J FAU - Liu, Cheng-Wei AU - Liu CW FAU - Zhang, Zhi-Shen AU - Zhang ZS FAU - Yang, De-Hua AU - Yang DH LA - chi PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - China TA - Zhonghua Yi Xue Za Zhi JT - Zhonghua yi xue za zhi JID - 7511141 RN - 0 (RNA, Small Interfering) RN - EC 2.7.- (Protein Kinases) RN - EC 2.7.11.1 (TOR Serine-Threonine Kinases) SB - IM MH - Animals MH - Apoptosis MH - Blood Vessels/transplantation MH - Blotting, Western MH - Cell Differentiation MH - *Cell Proliferation MH - Female MH - Genetic Therapy MH - Hyperplasia MH - Immunohistochemistry MH - Male MH - Muscle, Smooth, Vascular/cytology/*metabolism MH - Myocytes, Smooth Muscle/cytology/metabolism MH - Protein Kinases/genetics/*metabolism MH - *RNA Interference MH - RNA, Small Interfering/genetics MH - Rats MH - Rats, Wistar MH - TOR Serine-Threonine Kinases MH - Transfection MH - Tunica Intima/metabolism/*pathology/surgery EDAT- 2007/04/04 09:00 MHDA- 2008/10/22 09:00 CRDT- 2007/04/04 09:00 PHST- 2007/04/04 09:00 [pubmed] PHST- 2008/10/22 09:00 [medline] PHST- 2007/04/04 09:00 [entrez] PST - ppublish SO - Zhonghua Yi Xue Za Zhi. 2007 Jan 2;87(1):58-62.